Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO.
Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO.
复制标题
在团体模型 HMO 中转诊治疗酒精和其他药物使用障碍后的医疗费用抵消。
DOI：
10.1007/s11414-006-9020-8
复制
发表时间：
2006
期刊：
影响因子：
--
通讯作者：
Dickinson,DanielM
中科院分区：
文献类型：
--
作者：
Polen,MichaelR;Freeborn,DonaldK;Lynch,FrancesL;Mullooly,JohnP;Dickinson,DanielM
本研究的目的是确定特种酒精和其他药物 (AOD) 治疗是否与减少后续医疗费用相关。收集了团体模型健康维护组织 (HMO) 长达 6 年的 AOD 治疗费用和医疗费用，包括 1,472 名被推荐接受 AOD 专业治疗的 HMO 成员以及 738 名没有进行 AOD 诊断或治疗的成员。成瘾严重程度指数测量值也是从 293 名推荐治疗的样本中获得的。治疗组和对照组之间的医疗费用变化没有差异。治疗效果改善的个人的医疗费用也没有大幅减少。除最近接受过 AOD 治疗的亚组外，AOD 治疗费用与后续医疗费用并无负相关关系。在受访样本中，更好的治疗结果并不意味着后续医疗费用会更低。多次治疗可能有望产生成本抵消。
The purpose of this study was to determine whether specialty alcohol and other drug (AOD) treatment is associated with reduced subsequent medical care costs. AOD treatment costs and medical costs in a group model health maintenance organization (HMO) were collected for up to 6 years on 1,472 HMO members who were recommended for specialty AOD treatment, and on 738 members without AOD diagnoses or treatment. Addiction Severity Index measures were also obtained from a sample of 293 of those recommended for treatment. Changes in medical costs did not differ between treatment and comparison groups. Nor did individuals with improved treatment outcomes have greater reductions in medical costs. AOD treatment costs were not inversely related to subsequent medical costs, except for a subgroup with recent AOD treatment. In the interviewed sample, better treatment outcomes did not predict lower subsequent medical costs. Multiple treatment episodes may hold promise for producing cost-offsets.